Boston Scientific Announces European Approval and Market Launch of New Family of Advanced ...(tained in this document. CONTACT: Pa...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
Date:5/7/2008
tained in this document.
CONTACT: Paul Donovan
508-650-8541 (office)
508-667-5165 (mobile)
Media Relations
Boston Scientific Corporation
Larry Neumann
508-650-8696 (office)
Investor Relations
Boston Scientific Corporation
'/>"/>
| SOURCE Boston Scientific Corporation Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. WIPO Panel Rules Boston Scientific Liberte(R) and TAXUS(R) Liberte(R) Stents Do Not Infringe Medinol Patents
2. Fraunhofer and Boston University Hosted Prestigious SME Tour
3. Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection
4. Boston Scientific Announces Results for First Quarter Ended March 31, 2008
5. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
6. Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System
7. Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement
8. Boston Scientific and Surgi-Vision Announce Licensing Agreement for MRI-Safe Technology
9. Boston Scientific Announces Japanese Approval of Heart Failure Lead
10. Boehringer Ingelheim and BioSpace Search for Scientists at Career Fair in Boston, Massachusetts
11. Boston Scientific to Webcast Conference Call Discussing First Quarter Financial Results
Post Your Comments:
Breaking Biology Technology:YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Biomatrica Launches SampleWare 3.1 2Biomatrica Launches SampleWare 3.1 3Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 2Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 3
[0] YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT[0] Biomatrica Launches SampleWare 3.1[0] Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years[0] Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum
Other Biology Technology:RNeasy Mini, Midi, and Maxi Kits 2RNeasy Mini, Midi, and Maxi Kits 3RNeasy Mini, Midi, and Maxi Kits 4QIAfilter Plasmid Kits 2HiSpeed Plasmid Kits 2
Breaking Biology News(10 mins):New inherited eye disease discovered 2Kornberg Associates | Architects Completes UC Riverside Stem Cell Core Facility Project 2Corn Refiners Association Comments on Findings in Recent Report on Sugars and High Blood Pressure 58297 1Corn Refiners Association Comments on Findings in Recent Report on Sugars and High Blood Pressure 58297 2Health Related Tourism Catching On 58294 1Health Related Tourism Catching On 58294 2Virginia Now Owns Three Top National Business Rankings 14267 1Virginia Now Owns Three Top National Business Rankings 14267 2
Other Biology News:A 'traffic light' for neurons means 'go' for improving brain research 2A 'traffic light' for neurons means 'go' for improving brain research 3A 'traffic light' for neurons means 'go' for improving brain research 4Mechanism of nicotine's learning effects explored 2Glucose triggers brain cell death in rats after hypoglycemic coma 2Glucose triggers brain cell death in rats after hypoglycemic coma 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |